Abstract: A methodology that enables introduction of an innovative assay for evaluating the extra-virgin olive oil (EOO), based upon the quantification of the main components of the saponifiable and non-saponifiable fractions of EOOs and upon its total antioxidizing power.

Abstract: A cosmetic formulation, including active principles of strictly natural origin to protect skin against exogenous or endogenous harmful agents as well as to balance again the dermal homeostasis lipids altered by dermatosis and ageing, is characterized by a lipid composition which is close to the human sebum, has a pool of antioxidants similar to those present in sebum and skin, and has anti-inflammatory and anti-free-radical molecules capable of preventing histidine from being decarboxylated and then histamine to be formed.

Abstract: A preparation similar to sebum to be used as lipidic component in formulations to be administered topically is characterized in that it consits of active principale of only natural origin capable of fulfilling the requirement of meeting the average qualitative-quantitative composition of the human dermal surface lipides. In particular, it consits of substances of natural origin capable of providing triglycerides which are rich in saturated, monounsaturated and diunsaturated acids, squalene, waxes, free and esterified cholesterol in quantities which are equivalent to those present in the human sebum.

Abstract: A formulation of a skin cream based on the synergical combination of three particular active principles—escin, bufemin and rutin—whose pharmacological action stimulating the venous and arterial branchings of the peripheral bloodstream and the perivasal tissues is further increased both by the presence of antioxidants and inhibitors of histidine decarboxylase and the high concentration in soya lecithin (3%) and sebum-similar oil (2-10 %) causing the active principles to penetrate the skin where the three active principles should perform their action. Said cream finds therapeutical application in the treatment of cellulitis and disorders connected to the inefficiency of the surface bloodstream, phlebopathy, phlebothrombosis, surface periphlebitis, sense of heaviness, fatigue and weariness of limbs, spasms, tumefaction and edema of inflammatory origin, ecchymosis and hematoma, and chilblains.

Abstract: The present invention relates to a dietary product comprising ubiquinone, stabilized vitamin E, phospholipids, selenuim in an organic form and L-methionin, which is effective to combat cell oxidative stress even to the extreme consequences thereof, for example cell decay, acquired and/or congenital immunodeficiency or other alterations in the immune system. The dietary product object of the present invention is also effective as a coadjutant in the treatment of apoptosis, in mutagenesis and/or carcinogenesis, in infectious diseases of viral or bacterial origin or those deriving from other external pathogens, in myelinic and skin diseases, in cardiovascular diseases and in allergies.

Abstract: New stable derivatives of ubiquinole are described, having general formula (I), along with processes for their production and their pharmaceutical use, in particular in the treatment of intracellular oxidative stress and diseases involving oxidative stress of this kind.

Abstract: A pharmaceutical product to be used as an adjuvant treatment of seborrheic dermatitis even in HIV positive subjects is disclosed. The pharmaceutical product makes use of methionine, vitamin E and selenium as active principles which directly or indirectly provide a protective response to the damage caused by lipoperoxidation. The pharmaceutical product, in combination with a diet rich in PUFA-PL (polyunsaturated fatty acids of phospholipids), causes skin homeostasis to be restored and the symptoms of skin dermatitis to regress.